No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 1.4x · 10Y median 1.3x · 75th percentile · as of Sep 11, 2026
Annualized revenue (TTM) · by quarter, last 11
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-09-25T00:15:38.099Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-09-25T00:15:38.099Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-09-25T00:15:38.099Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-09-25T00:15:38.099Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-09-25T00:15:38.099Z. Latest historical point 2026-09-11.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-09-25T00:15:38.099Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-09-25T00:15:38.099Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-09-25T00:15:38.099Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Everus Construction Group, Inc. (ECG) stock was $116.70 as of Sep 24, 2026, 4:00 PM EDT, up 1.50% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +50.8%
Everus Construction Group, Inc. specializes in developing utility infrastructure.
Engineering & Construction · Bismarck, ND
LATEST PRICE
$116.7
52-WEEK RANGE
$77.86 - $171.58
BETA
2.40
% FROM 52W HIGH
-31.98%
MARKET CAP
$5.96B
DIVIDEND YIELD
Never paid
N/A
PE RATIO
trailing TTM
23.48
PE RATIO (FWD)
forward FY estimate
22.02
P/B RATIO
7.70
P/S RATIO
TTM
1.40
P/OCF RATIO
TTM
18.55
EV/EBITDA
TTM
16.81
DEBT / EQUITY
0.47
REVENUE TTM
$4.27B
GROSS MARGIN TTM
13.02%
NET PROFIT MARGIN TTM
5.96%
REVENUE GROWTH TTM
TTM vs prior TTM
+30.53%
REVENUE CAGR 3Y
+11.54%
REVENUE CAGR 5Y
N/A
TTM TOTAL RETURN
+50.83%
3Y TOTAL RETURN
annualized (CAGR)
N/A
5Y TOTAL RETURN
annualized (CAGR)
N/A
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Nov 3, 2026
39 days away
EPS Estimate
1.28
Revenue Est.
$1.19B
Last Quarter Results
EPS
$1.64
vs Estimate
$1.14
Revenue
$1.23B
vs Estimate
$1.08B
Consensus Rating
Based on 6 analysts
Average Price Target
$176.00
+50.8% upside
Low
$152.00
Current
$116.70
High
$200.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $1.29 | $1.31 | $1.33 | 4 |
| Quarter ending Dec 2026 | $1.20 | $1.21 | $1.26 | 3 |
| Quarter ending Mar 2027 | $1.31 | $1.35 | $1.40 | 1 |
| Quarter ending Jun 2027 | $1.62 | $1.67 | $1.74 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $5.25 | $5.30 | $5.35 | 5 |
| FY 2027 | $5.52 | $5.98 | $6.38 | 5 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $1.17B | $1.19B | $1.20B | 4 |
| Quarter ending Dec 2026 | $1.19B | $1.20B | $1.23B | 4 |
| Quarter ending Mar 2027 | $1.18B | $1.21B | $1.24B | 2 |
| Quarter ending Jun 2027 | $1.32B | $1.35B | $1.39B | 2 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $4.64B | $4.66B | $4.68B | 5 |
| FY 2027 | $4.99B | $5.21B | $5.42B | 5 |
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 31, 2026, matching Key Metrics.
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1ECG | $5.96B | $116.70 | +1.50% | +50.83% | N/A | N/A | N/A |
| 2POOL | $5.89B | $161.71 | -2.94% | -46.23% | -17.71% | +7.52% | vs ECG |
| 3PL | $5.87B | $17.62 | +7.57% | +70.18% | +10.65% | N/A | vs ECG |
| 4ENS | $6.46B | $177.13 | -1.31% | +68.32% | +18.58% | +11.26% | vs ECG |
| 5CWST | $5.25B | $83.83 | -1.14% | -3.04% | +3.44% | +25.90% | vs ECG |
| 6MSM | $6.74B | $120.73 | -2.72% | +35.41% | +12.65% | +10.17% | vs ECG |
